On 2025-05-08, Sutro Biopharma, Inc. (STRO) announced earnings per share of $-0.91 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.63.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.44 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.63 | $-0.91 |
| 2025-03-13 | 2024-12-31 | $-0.86 | $-0.89 |
| 2024-11-13 | 2024-09-30 | $-0.74 | $-0.59 |
| 2024-08-13 | 2024-06-30 | $-0.76 | $-0.59 |
| 2024-05-13 | 2024-03-31 | $-0.92 | $-0.95 |
| 2024-03-25 | 2023-12-31 | $-0.82 | $0.42 |
| 2023-11-13 | 2023-09-30 | $-0.76 | $-0.81 |
| 2023-08-10 | 2023-06-30 | $-0.73 | $-0.64 |
| 2023-05-15 | 2023-03-31 | $-0.83 | $-0.76 |
| 2023-03-30 | 2022-12-31 | $-0.64 | $-0.61 |
| 2022-11-08 | 2022-09-30 | $-0.15 | $-0.37 |
| 2022-08-08 | 2022-06-30 | $-0.74 | $-0.55 |
| 2022-05-09 | 2022-03-31 | $-0.79 | $-0.84 |
| 2022-02-28 | 2021-12-31 | $-0.67 | $-0.83 |
| 2021-11-10 | 2021-09-30 | $-0.67 | $-0.67 |
| 2021-08-09 | 2021-06-30 | $-0.42 | $-0.13 |
| 2021-05-07 | 2021-03-31 | $-0.61 | $-0.43 |
| 2021-03-18 | 2020-12-31 | $-0.56 | $-1.48 |
| 2020-11-05 | 2020-09-30 | $-0.44 | $-0.33 |
| 2020-08-06 | 2020-06-30 | $-0.59 | $-0.60 |
| 2020-05-11 | 2020-03-31 | $-0.69 | $-0.84 |
| 2020-03-16 | 2019-12-31 | $-0.77 | $-0.64 |
| 2019-11-08 | 2019-09-30 | $-0.64 | $-0.56 |
| 2019-08-14 | 2019-06-30 | $-0.62 | $-0.60 |
| 2019-05-15 | 2019-03-31 | $-0.60 | $-0.62 |
| 2018-11-14 | 2018-09-30 | -- | $-21.26 |